COmedication Study Assessing Mono- and cOmbination Therapy With Levodopa-carbidopa inteStinal Gel

Opicapone as Adjunctive Therapy to Levodopa-Carbidopa Intestinal Gel in Parkinson's Disease

NCT06432309 ·Status: COMPLETED ·Phase: NA

Levodopa-Carbidopa Intestinal Gel Open-Label Study in Advanced Parkinson's Disease

NCT00335153 ·Status: COMPLETED ·Phase: PHASE3

Long Term Effectiveness of Levodopa-Entacapone-Carbidopa Intestinal Gel in Participants With Advanced Parkinson's Disease

NCT07313176 ·Status: RECRUITING

Intestinal Levodopa + Entacapone Therapy (Lecigon®) to Counteract Dopaminergic Desensitization and Neuropsychiatric Complications in Parkinson's Disease

NCT07151378 ·Status: RECRUITING ·Phase: PHASE3

Prevention of Levodopa-induced Dyskinesias by Transcranial Static Magnetic Field Stimulation (tSMS)

NCT02657681 ·Status: COMPLETED ·Phase: PHASE2

A Pharmacokinetic Study of Levodopa and Carbidopa Intestinal Gel in Subjects With Advanced Parkinson's Disease

NCT01484990 ·Status: COMPLETED ·Phase: PHASE1

Study to Compare the Effect of Treatment With Carbidopa/Levodopa/Entacapone on the Quality of Life of Patients With Parkinson's Disease. This Study is Not Recruiting in the United States

NCT00143026 ·Status: COMPLETED ·Phase: PHASE4

Efficacy and Safety Proof of Concept Study in Patients With Parkinson's Disease and End-of-dose Wearing-off (COMPOC)

NCT02764125 ·Status: COMPLETED ·Phase: PHASE2

eArly levoDopa With Opicapone in Parkinson's paTients wIth motOr fluctuatioNs.

NCT04990284 ·Status: COMPLETED ·Phase: PHASE4

Duodopa Home Titration Using Telemedicine: Evaluation of Use of Resources

NCT01956032 ·Status: COMPLETED

Motor Cortex Stimulation for Parkinson's Disease

NCT00637260 ·Status: COMPLETED ·Phase: NA

Basic and Clinical Studies of Levodopa/Carbidopa/Entacapone in the Treatment of Early Parkinson's Disease

NCT06236230 ·Status: RECRUITING ·Phase: PHASE4

Efficacy and Safety Proof of Concept Study in Patients With Parkinson's Disease and End-of-dose Motor Fluctuations

NCT01766258 ·Status: COMPLETED ·Phase: PHASE2

Safety and Tolerability Study Evaluating ACR325 in Parkinson's Disease Patients

NCT01023282 ·Status: COMPLETED ·Phase: PHASE1

A Trial of Fecal Microbiome Transplantation in Parkinson's Disease Patients

NCT04854291 ·Status: COMPLETED ·Phase: NA

Health Related Quality of Life in LCIG Patients and LCIG Eligible Patients Continuing Oral Therapy

NCT02381444 ·Status: COMPLETED

Comtess® Versus Cabaseril® as Add-on to Levodopa in the Treatment of Parkinsonian Patients Suffering From Wearing- Off.

NCT00247247 ·Status: COMPLETED ·Phase: PHASE4

A Study of AP-CD/LD in Fluctuating Parkinson's Disease Patients Who Completed IN 11 004

NCT02615873 ·Status: UNKNOWN ·Phase: PHASE3

Remission of ICD by Switching Dopamine Agonist to Levodopa/Carbidopa

NCT01683253 ·Status: COMPLETED ·Phase: PHASE4

Study of Sexuality in Parkinson Disease

NCT01878409 ·Status: COMPLETED

A Study in Parkinson's Disease in Patients With Moderate to Severe Dyskinesia

NCT03956979 ·Status: COMPLETED ·Phase: PHASE2

DESENSITIZE-PD: Intestinal Levodopa + Entacapone Therapy (Lecigon®) to Support Dopaminergic Desensitization in PD

NCT05579379 ·Status: UNKNOWN

Study of the Effects of Dopaminergic Medications on Dopamine Transporter Density in Subjects With Parkinson's Disease

NCT00129181 ·Status: COMPLETED ·Phase: NA

PharmacoMRI of Parkinson Disease

NCT01528592 ·Status: COMPLETED ·Phase: NA

Efficacy and Safety of JM-010 in PD With Levodopa-Induced Dyskinesia

NCT02439203 ·Status: COMPLETED ·Phase: PHASE2